Eli Lilly & Co. (LLY)
1,115.70
-7.30 (0.65%)
Upcoming Events
Latest Headlines
Form 4 ELI LILLY & Co For: Sep 22 Filed by: Seymour Melissa
September 11, 2026 4:16 PM - SEC Filing
Lilly completes acquisition of AtaiBeckley for mental health pipeline
September 11, 2026 9:02 AM - StreetInsider
Lilly completes acquisition of AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions
September 11, 2026 9:02 AM - PR NewsWire
Eli Lilly (LLY) PT Raised to $940 at HSBC
September 10, 2026 3:28 AM - StreetInsider
BMO Capital on Eli Lilly's (LLY) Positioning for 2H26
September 9, 2026 8:11 AM - StreetInsider
Form 3/A ELI LILLY & Co For: Nov 07 Filed by: Brown Adrienne S
September 4, 2026 4:22 PM - SEC Filing
Form 4 ELI LILLY & Co For: Sep 02 Filed by: Hernandez Edgardo
September 4, 2026 4:19 PM - SEC Filing
Form 4 ELI LILLY & Co For: Sep 02 Filed by: Dozier Eric
September 4, 2026 4:17 PM - SEC Filing
Bessent at Charlotte Private Luncheon warns China AI win would 'negate all else', targets 80% compute share by 2028
September 3, 2026 5:25 AM - StreetInsider
JPMorgan Reiterates Overweight Rating on Eli Lilly (LLY)
September 2, 2026 9:29 AM - StreetInsider
Lilly to participate in Morgan Stanley 24th Annual Global Healthcare Conference
September 1, 2026 10:00 AM - PR NewsWire
BMO Capital: 'Eli Lilly (LLY) to Acquire Precision I&I Biotech Merida Bio'
September 1, 2026 9:14 AM - StreetInsider
Lilly reports one-year data on Taltz and Zepbound combined in psoriatic disease
August 31, 2026 7:01 AM - StreetInsider
New Phase 3b data on Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together showed improved and durable efficacy at one year in adults with psoriatic disease and obesity
August 31, 2026 7:00 AM - PR NewsWire
Lilly to buy Merida Biosciences for up to $2.875 billion
August 31, 2026 6:45 AM - StreetInsider
Lilly to acquire Merida Biosciences to advance treatments for serious autoimmune and allergic diseases
August 31, 2026 6:45 AM - PR NewsWire
FDA clears Lilly's Mounjaro for cardiovascular risk in type 2 diabetes
August 28, 2026 7:00 AM - StreetInsider
FDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes
August 28, 2026 7:00 AM - PR NewsWire
Novo Nordisk seeks China approval for oral Wegovy drug
August 27, 2026 8:27 AM - StreetInsider
Lilly study links Zepbound to lower costs in adults over 55
August 26, 2026 6:45 AM - StreetInsider
Zepbound linked to lower healthcare costs in adults over age 55 with obesity according to a real-world study
August 26, 2026 6:45 AM - PR NewsWire
PepsiCo Scraps Coverage of Weight-Loss Drugs for Employees - Bloomberg
August 25, 2026 1:54 PM - StreetInsider
Amplitude Therapeutics signs taRNA vaccine deal with Eli Lilly
August 19, 2026 3:33 PM - StreetInsider
Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.
August 19, 2026 8:56 AM - StreetInsider
Form 4 ELI LILLY & Co For: Aug 17 Filed by: Sulzberger Gabrielle
August 18, 2026 4:25 PM - SEC Filing
Form 4 ELI LILLY & Co For: Aug 17 Filed by: LUCIANO JUAN R
August 18, 2026 4:24 PM - SEC Filing
Form 4 ELI LILLY & Co For: Aug 17 Filed by: Fyrwald J Erik
August 18, 2026 4:23 PM - SEC Filing
Form 4 ELI LILLY & Co For: Aug 17 Filed by: Alvarez Ralph
August 18, 2026 4:22 PM - SEC Filing
Form 4 ELI LILLY & Co For: Aug 17 Filed by: Jonsson Patrik
August 18, 2026 4:21 PM - SEC Filing
A New Category Is Forming in Medical Aesthetics. Independent Research Has Started Sizing It.
August 18, 2026 12:57 PM - Globe NewsWire
Form 144 ELI LILLY & Co Filed by: Jonsson Patrik
August 17, 2026 5:06 PM - SEC Filing
Morgan Stanley analysts visit National Resilience facility in Ohio, clients include LLY and AZN
August 12, 2026 12:04 PM - StreetInsider
The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For
August 12, 2026 9:15 AM - StreetInsider
Lilly files six lawsuits over illegal sales of unapproved retatrutide
August 12, 2026 5:57 AM - StreetInsider
Lilly calls on online platforms, payment companies and regulators to shut down the illegal retatrutide black market
August 12, 2026 5:30 AM - PR NewsWire
Form 4 ELI LILLY & Co For: Aug 10 Filed by: Zakrowski Donald A
August 11, 2026 4:32 PM - SEC Filing
Eli Lilly selects Veeva Vault CRM for global deployment
August 11, 2026 7:03 AM - StreetInsider
BofA raises obesity market forecast on Lilly stock international strength
August 11, 2026 6:44 AM - StreetInsider
Form 144 ELI LILLY & Co Filed by: Zakrowski Donald A
August 10, 2026 4:32 PM - SEC Filing
Form 4 ELI LILLY & Co For: Aug 07 Filed by: Hakim Anat
August 10, 2026 4:20 PM - SEC Filing
Eli Lilly's weight-loss pill secures first European nod in Britain
August 10, 2026 2:49 PM - StreetInsider
Form 144 ELI LILLY & Co Filed by: Hakim Anat
August 7, 2026 10:30 AM - SEC Filing
Eli Lilly (LLY) PT Raised to $1,419 at Morgan Stanley
August 6, 2026 8:51 AM - StreetInsider
Eli Lilly (LLY) PT Raised to $1,330 at Wells Fargo
August 6, 2026 6:09 AM - StreetInsider
Eli Lilly (LLY) PT Raised to $1,400 at BMO Capital
August 6, 2026 5:07 AM - StreetInsider
Form 10-Q ELI LILLY & Co For: Jun 30
August 5, 2026 2:41 PM - SEC Filing
Eli Lilly shares pop as weight-loss drug demand fuels guidance hike
August 5, 2026 7:19 AM - StreetInsider
Form 8-K ELI LILLY & Co For: Aug 05
August 5, 2026 7:05 AM - SEC Filing
Eli Lilly & Co. (LLY) Misses Q2 EPS by 46c ; Offers Guidance
August 5, 2026 6:48 AM - StreetInsider
Novo Nordisk tumbles as Wegovy sales miss, trial setback overshadow raised outlook
August 5, 2026 6:46 AM - StreetInsider
Lilly reports second-quarter 2026 financial results, raises full-year guidance, and highlights continued growth and pipeline progress
August 5, 2026 6:45 AM - PR NewsWire
Earnings preview: Bernstein sees ‘clear potential for further upside’ in this stock
August 5, 2026 4:04 AM - StreetInsider
Eli Lilly & Co. (LLY) call put ratio 1 call to 1.4 puts into quarter results
August 4, 2026 11:22 AM - StreetInsider
Eli Lilly & Co. (LLY) call put ratio 1 call to 1 put into quarter results
August 4, 2026 4:41 AM - StreetInsider
Form 4 ELI LILLY & Co For: Aug 01 Filed by: Seymour Melissa
August 3, 2026 4:43 PM - SEC Filing
Eli Lilly & Co. (LLY) call put ratio 1 call to 1.5 puts with into quarter results
August 3, 2026 11:00 AM - StreetInsider
FDA grants Lilly's olomorasib breakthrough therapy status for pancreatic cancer
August 3, 2026 7:45 AM - StreetInsider
Lilly's olomorasib receives U.S. FDA's Breakthrough Therapy designation for the treatment of previously treated KRAS G12C-mutant advanced pancreatic cancer
August 3, 2026 7:45 AM - PR NewsWire
U.S. biopharma earnings: Eli Lilly (LLY), Pfizer (PFE) take the stage
August 1, 2026 10:00 AM - StreetInsider
Eli Lilly and Resilience to invest $750 million in US manufacturing
July 30, 2026 8:59 AM - StreetInsider
Lilly to file for next-gen obesity drug approval in early 2027
July 23, 2026 10:54 AM - StreetInsider
Form SCHEDULE 13G/A ELI LILLY & Co Filed by: LILLY ENDOWMENT INC
July 23, 2026 10:12 AM - SEC Filing
Lilly's retatrutide meets goals in two Phase 3 obesity trials
July 23, 2026 6:45 AM - StreetInsider
Lilly's triple agonist, retatrutide, successful in two additional Phase 3 obesity trials, delivering significant improvements in weight and A1C
July 23, 2026 6:45 AM - PR NewsWire
Lilly confirms date and conference call for second-quarter 2026 financial results announcement
July 22, 2026 10:00 AM - PR NewsWire
Form 4 ELI LILLY & Co For: Jul 20 Filed by: Sulzberger Gabrielle
July 21, 2026 4:41 PM - SEC Filing
Form 4 ELI LILLY & Co For: Jul 20 Filed by: LUCIANO JUAN R
July 21, 2026 4:40 PM - SEC Filing
Form 4 ELI LILLY & Co For: Jul 20 Filed by: Fyrwald J Erik
July 21, 2026 4:39 PM - SEC Filing
Form 4 ELI LILLY & Co For: Jul 20 Filed by: Alvarez Ralph
July 21, 2026 4:38 PM - SEC Filing
Novo Nordisk sues Eli Lilly in high-stakes GLP-1 advertising feud
July 21, 2026 7:53 AM - StreetInsider
Novo Nordisk sues Eli Lilly over weight-loss drug ads
July 21, 2026 7:36 AM - StreetInsider
H.C. Wainwright Downgrades AtaiBeckley Inc (ATAI) to Neutral
July 20, 2026 7:17 AM - StreetInsider
UBS Reiterates Buy Rating on Eli Lilly (LLY) on Deal to Acquire ATAI
July 17, 2026 9:13 AM - StreetInsider
Oppenheimer on AtaiBeckley Inc (ATAI): 'LLY Acquisition Validates Psychedelic Advantages'
July 16, 2026 10:00 AM - StreetInsider
Eli Lilly to acquire AtaiBeckley for up to $3.8B
July 16, 2026 6:45 AM - StreetInsider
Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions
July 16, 2026 6:45 AM - PR NewsWire
Lilly Said To Near Deal For Psychedelic Drugmaker Ataibeckley - Bloomberg
July 15, 2026 7:09 PM - StreetInsider
Three Biotechs Deliver Catalysts to Watch
July 15, 2026 10:43 AM - StreetInsider
Eli Lilly (LLY) PT Raised to $1,600 at Citi
July 15, 2026 5:02 AM - StreetInsider
Lilly’s Retevmo approved by FDA for RET Tumors
July 14, 2026 2:27 PM - StreetInsider
Eli Lilly (LLY) PT Raised to $1,385 at Bernstein SocGen Group
July 14, 2026 6:20 AM - StreetInsider
Teva lawsuit against Eli Lilly over Forteo revived by appeals court
July 13, 2026 3:27 PM - StreetInsider
Eli Lilly (LLY) PT Raised to $1,273 at Guggenheim
July 13, 2026 6:51 AM - StreetInsider
/C O R R E C T I O N -- Eli Lilly and Company/
July 9, 2026 1:17 PM - PR NewsWire
Lilly to present 16 Alzheimer's abstracts at AAIC 2026 in London
July 9, 2026 7:31 AM - StreetInsider
Lilly to present Alzheimer's disease diagnostic and therapeutic research at AAIC 2026, including new data on P-tau217 blood tests and amyloid-targeting treatment
July 9, 2026 7:30 AM - PR NewsWire
Eli Lilly: Q2 2026 IPR&D charge estimated at $3.02 per share on GAAP and non-GAAP basis
July 8, 2026 4:36 PM - StreetInsider
Eli Lilly (LLY) PT Raised to $1,370 at Truist Securities
July 8, 2026 8:52 AM - StreetInsider
Eli Lilly (LLY) PT Raised to $1,347 at Morgan Stanley
July 8, 2026 8:08 AM - StreetInsider
Eli Lilly (LLY) PT Raised to $1,500 at RBC Capital
July 8, 2026 7:41 AM - StreetInsider
Form 144 ELI LILLY & Co Filed by: LILLY ENDOWMENT INC
July 7, 2026 3:02 PM - SEC Filing
Eli Lilly (LLY) PT Raised to $1,400 at JPMorgan
July 7, 2026 8:16 AM - StreetInsider
Eli Lilly (LLY) PT Raised to $1,350 at Cantor Fitzgerald as Strong Q2 Results Likely
July 6, 2026 6:45 AM - StreetInsider
Abbvie (ABBV) PT Raised to $265 at Cantor Fitzgerald: Broadly Strong Q2 Results Expected
July 6, 2026 6:43 AM - StreetInsider
A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity
July 1, 2026 9:05 AM - StreetInsider
RBC Capital Reiterates Outperform Rating on Eli Lilly (LLY)
July 1, 2026 7:59 AM - StreetInsider
Innovent and Lilly strike China deal for breast cancer drug
June 30, 2026 3:26 AM - StreetInsider
Innovent Biologics and Lilly Enter into Commercialization Agreement for Verzenios® (abemaciclib) in Mainland China
June 30, 2026 12:00 AM - PR NewsWire
FDA selects seven participants for precheck pilot program to advance U.S. drug manufacturing
June 29, 2026 4:28 PM - StreetInsider
FDA selects 7 companies for domestic drug manufacturing pilot
June 29, 2026 4:20 PM - StreetInsider
Sandoz submits generic obesity drug applications to FDA
June 29, 2026 6:14 AM - StreetInsider
Form 144 ELI LILLY & Co Filed by: LILLY ENDOWMENT INC
June 26, 2026 1:40 PM - SEC Filing
Lilly's Jaypirca gets EU approval recommendation for CLL
June 26, 2026 7:17 AM - StreetInsider
Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) across all lines of therapy
June 26, 2026 7:16 AM - PR NewsWire
What Medicare Part D patients need to know about accessing Foundayo (orforglipron) and Zepbound (tirzepatide) for weight management
June 25, 2026 6:45 AM - PR NewsWire
Lilly completes acquisition of Centessa Pharmaceuticals
June 24, 2026 8:45 AM - StreetInsider
Lilly completes acquisition of Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
June 24, 2026 8:45 AM - PR NewsWire
Form 11-K ELI LILLY & Co For: Dec 31
June 23, 2026 3:27 PM - SEC Filing
Eli Lilly plans European weight-loss pill launch by early 2027
June 23, 2026 12:20 PM - StreetInsider
Sangamo files Chapter 11, agrees to sell assets to Lilly, Astellas
June 23, 2026 8:05 AM - StreetInsider
Eli Lilly & Co. (LLY) Declares $1.73 Quarterly Dividend; 0.6% Yield
June 22, 2026 11:00 AM - StreetInsider
Lilly declares third-quarter 2026 dividend
June 22, 2026 11:00 AM - PR NewsWire
International Regulatory Pathways Have Supported Drug Development Across Biotech and Pharma
June 22, 2026 9:05 AM - StreetInsider
This digital health stock is ready to re-rate higher: Goldman
June 22, 2026 9:00 AM - StreetInsider
Eli Lilly (LLY) Reiterated at Overweight by Cantor Fitzgerald as Injectable Obesity TRx Down
June 22, 2026 7:37 AM - StreetInsider
Oral Wegovy reaches 33% of total prescriptions by May
June 18, 2026 5:47 AM - StreetInsider
Form 4 ELI LILLY & Co For: Jun 15 Filed by: Sulzberger Gabrielle
June 16, 2026 4:26 PM - SEC Filing
Form 4 ELI LILLY & Co For: Jun 15 Filed by: LUCIANO JUAN R
June 16, 2026 4:25 PM - SEC Filing
Form 4 ELI LILLY & Co For: Jun 15 Filed by: Fyrwald J Erik
June 16, 2026 4:14 PM - SEC Filing
Form 4 ELI LILLY & Co For: Jun 15 Filed by: Alvarez Ralph
June 16, 2026 4:13 PM - SEC Filing
Full Article List
